TPTX » Topics » Item 9.01. Results of Operations and Financial Condition.

This excerpt taken from the TPTX 8-K filed Mar 26, 2008.

Item 9.01.              Results of Operations and Financial Condition.

 

(d)                                 The following exhibit is furnished herewith:

 

99.1

 

Press release dated March 26, 2008.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

TORREYPINES THERAPEUTICS, INC.

 

 

 

 

Date: March 26, 2008

 

 

By:

    /s/ Craig Johnson

 

Name: Craig Johnson

 

Title: Vice President, Finance and

 

 

Chief Financial Officer

 

3



 

INDEX TO EXHIBITS

 

Exhibit 
Number

 

Description

99.1

 

Press release dated March 26, 2008

 

4


This excerpt taken from the TPTX 8-K filed Nov 14, 2007.

Item 9.01.              Results of Operations and Financial Condition.

(d)                                        The following exhibit is furnished herewith:

99.1                 Press release dated November 14, 2007.

 

2



 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

TORREYPINES THERAPEUTICS, INC.

 

 

 

Date: November 14, 2007

 

 

 

By:

/s/ Craig Johnson

 

 

Name:

Craig Johnson

 

Title:

Vice President, Finance and

 

 

Chief Financial Officer

 

 

 

 

3



 

INDEX TO EXHIBITS

 

 

Exhibit Number

 

Description

99.1

 

Press release dated November 14, 2007

 

4


This excerpt taken from the TPTX 8-K filed Aug 14, 2007.

Item 9.01.              Results of Operations and Financial Condition.

(d)                   The following exhibit is furnished herewith:

99.1                 Press release dated August 13, 2007.

2




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

TORREYPINES THERAPEUTICS, INC.

 

 

 

 

 

 

Date: August 13, 2007

 

 

 

 

By:

 

/s/ Craig Johnson

 

 

Name:

 

Craig Johnson

 

 

Title:

 

Vice President, Finance and

 

 

 

 

Chief Financial Officer

 

 

 

 

 

 

3




INDEX TO EXHIBITS

Exhibit
Number

 

Description

99.1

 

Press release dated August 13, 2007

 

4



This excerpt taken from the TPTX 8-K filed May 14, 2007.

Item 9.01.              Results of Operations and Financial Condition.

(d)                                 The following exhibit is furnished herewith:

99.1                 Press release dated May 14, 2007.

2




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

TORREYPINES THERAPEUTICS, INC.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Date: May 14, 2007

 

 

 

 

 

 

 

 

 

By:

/s/ Craig Johnson

 

 

 

Name:

Craig Johnson

 

 

 

Title:

Vice President, Finance and

 

 

 

 

 Chief Financial Officer

 

3




INDEX TO EXHIBITS

Exhibit

 

 

Number

 

Description

99.1

 

Press release dated May 14, 2007

 

4



This excerpt taken from the TPTX 8-K filed Mar 29, 2007.

Item 9.01.              Results of Operations and Financial Condition.

(d)                                 The following exhibit is furnished herewith:

99.1 Press release dated March 29, 2007.

2




 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

TORREYPINES THERAPEUTICS, INC.

 

 

 

Date: March 29, 2007

 

 

 

 

 

 

By:

/s/ Craig Johnson

 

Name:

Craig Johnson

 

Title:

Vice President, Finance and

 

 

Chief Financial Officer

 

3




INDEX TO EXHIBITS

Exhibit
Number

 

Description

99.1

 

Press release dated March 29, 2007

 

 

4



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki